期刊文献+

Colon cancer stem cells:Controversies and perspectives 被引量:5

Colon cancer stem cells:Controversies and perspectives
下载PDF
导出
摘要 Tumors have long been viewed as a population in which all cells have the equal propensity to form new tumors,the so called conventional stochastic model.The cutting-edge theory on tumor origin and progression,tends to consider cancer as a stem cell disease.Stem cells are actively involved in the onset and maintenance of colon cancer.This review is intended to examine the state of the art on colon cancer stem cells(CSCs),with regard to the recent achievements of basic research and to the corresponding translational consequences.Specific prominence is given to the hypothesized origin of CSCs and to the methods for their identification.The growing understanding of CSC biology is driving the optimization of novel anti-cancer targeted drugs. Tumors have long been viewed as a population in which all cells have the equal propensity to form new tumors, the so called conventional stochastic model. The cutting-edge theory on tumor origin and progression, tends to consider cancer as a stem cell disease. Stem cells are actively involved in the onset and maintenance of colon cancer. This review is intended to examine the state of the art on colon cancer stem cells (CSCs), with regard to the recent achievements of basic research and to the corresponding translational consequences. Specific prominence is given to the hypothesized origin of CSCs and to the methods for their identification. The growing understanding of CSC biology is driving the optimization of novel anti-cancer targeted drugs.
出处 《World Journal of Gastroenterology》 SCIE CAS 2013年第20期2997-3006,共10页 世界胃肠病学杂志(英文版)
关键词 COLON CANCER stem cells COLORECTAL CANCER CD133 Therapy CHEMORESISTANCE Colon cancer stem cells Colorectal cancer CD133 Therapy Chemoresistance
  • 相关文献

参考文献13

  • 1Feng Li,Benjamin Tiede,Joan Massague,Yibin Kang.Beyond tumorigenesis: cancer stem cells in metastasis[J].Cell Research,2007,17(1):3-14. 被引量:86
  • 2Igor Pantic.Cancer stem cell hypotheses: Impact on modern molecular physiology and pharmacology research[J].Journal of Biosciences.2011(5)
  • 3Susumu Saigusa MD,Koji Tanaka MD,Yuji Toiyama MD,Takeshi Yokoe MD,Yoshinaga Okugawa MD,Yasuhiro Ioue MD, PhD,Chikao Miki MD, PhD,Masato Kusunoki MD, PhD.Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy[J].Annals of Surgical Oncology.2009(12)
  • 4Papailiou J,Bramis KJ,Gazouli M,Theodoropoulos G.Stem cells in colon cancer. A new era in cancer theory begins[].International Journal of Colorectal Disease.2011
  • 5E Sangiorgi,MR Capecchi.Bmi1 is expressed in vivo in intestinal stem cells[].Nature Genetics.2008
  • 6JM Houghton,C Stoicov,S Nomura,AB Rogers,J Carlson,H Li,X Cai,JG Fox,JR Goldenring,TC Wang.Gastric cancer originating from bone marrow–derived cells[].Science.2004
  • 7Jemal A,Siegel R,Ward E, et al.Cancer statistics, 2006[].CA A Cancer Journal for Clinicians.2006
  • 8Fearon E R,Vogelstein B.A genetic model for colorectal tumorigenesis[].Cell.1990
  • 9Bonnet D,Dick JE.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[].Nature Medicine.1997
  • 10Ricci-Vitiani L,Lombardi DG,Pilozzi E,et al.Identification and expansion of human colon-cancer-initiating cells[].Nature.2007

二级参考文献139

  • 1Bernards R. Cancer: cues for migration. Nature 2003; 425:247-248.
  • 2Li YM, Pan Y, Wei Y, et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 2004; 6:459-469.
  • 3Liang Z, Wu T, Lou H, et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 2004; 64:4302-4308.
  • 4John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001; 7:14-23.
  • 5Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2002; 2:826-835.
  • 6Pratap J, Javed A, Languino LR, et al. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol2005; 25:8581-8591.
  • 7Chinni SR, Sivalogan S, Dong Z, et al. CXCL 12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.Prostate 2006; 66:32-48.
  • 8Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109:625-637.
  • 9Janowska-Wieczorek A, Marquez LA, Dobrowsky A, Ratajczak MZ, Cabuhat ML. Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. Exp Hematol 2000; 28:1274-1285.
  • 10Kollet O, Shivtiel S, Chen YQ, et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003; 112:160-169.

共引文献85

同被引文献30

  • 1Meetings[J].World Journal of Gastroenterology,2010,16(5). 被引量:14
  • 2Masatsugu Hiraki,Yoshihiko Kitajima,Seiji Sato,Jun Nakamura,Kazuyoshi Hashiguchi,Hirokazu Noshiro,Kohji Miyazaki.Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer[J].World Journal of Gastroenterology,2010,16(3):330-338. 被引量:20
  • 3Fei Ren,Wei-Qi Sheng,Xiang Du.CD133:A cancer stem cells marker, is used in colorectal cancers[J].World Journal of Gastroenterology,2013,19(17):2603-2611. 被引量:19
  • 4Jean Paul Thiery,Hervé Acloque,Ruby Y.J. Huang,M. Angela Nieto.Epithelial-Mesenchymal Transitions in Development and Disease[J]. Cell . 2009 (5)
  • 5Krishnansu Tewari,Ramez N Eskander.Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer[J]. Clinical Pharmacology: Advances and Applications . 2013 (Supplement 1)
  • 6Amy P.N. Skubitz,Elizabeth P. Taras,Kristin L.M. Boylan,Nate N. Waldron,Seunguk Oh,Angela Panoskaltsis-Mortari,Daniel A. Vallera.Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression[J]. Gynecologic Oncology . 2013
  • 7Hongmei Sun,Jun Jia,Xiaoli Wang,Bo Ma,Lijun Di,Guohong Song,Jun Ren.CD44 + /CD24 ? breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties[J]. Clinical and Translational Oncology . 2013 (1)
  • 8Jessica J. Shank,Kun Yang,Jacob Ghannam,Lourdes Cabrera,Carolyn J. Johnston,R. Kevin Reynolds,Ronald J. Buckanovich.Metformin targets ovarian cancer stem cells in vitro and in vivo[J]. Gynecologic Oncology . 2012 (2)
  • 9Ignacio Romero Noguera,Charlotte C. Sun,Russell R. Broaddus,Donna Branham,Charles F. Levenback,Pedro T. Ramirez,Anil K. Sood,Robert L. Coleman,David M. Gershenson.Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube[J]. Gynecologic Oncology . 2012 (3)
  • 10Lijing Luo,Jianfang Zeng,Bing Liang,Zhe Zhao,Lulu Sun,Dongyan Cao,Jiaxin Yang,Keng Shen.Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome[J]. Experimental and Molecular Pathology . 2011 (2)

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部